Bulletin
Investor Alert

Oramed Pharmaceuticals Inc.

NAS: ORMP

GO
/marketstate/country/us

After Hours

/zigman2/quotes/208727845/composite

$

10.94

Change

0.00 0.00%

Volume

Volume 2,239

May 7, 2021, 4:54 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208727845/composite

Today's close

$ 10.62

$ 10.94

Change

+0.32 +3.01%

Day low

Day high

$10.64

$11.20

Open
Open: 10.64

52 week low

52 week high

$2.40

$12.73

Open

Market cap

$321.03M

Average volume

692,214

P/E ratio

N/A

Rev. per Employee

$225,833

EPS

-0.63

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ormp

MarketWatch News on ORMP

  1. Oramed Pharmaceuticals stock price target raised to $25 from $11 at Alliance Global Partners

    7:25 a.m. April 27, 2021

    - Tomi Kilgore

  2. Oramed Pharmaceuticals started at buy with $27 stock price target at Canaccord Genuity

    9:35 a.m. April 20, 2021

    - Tomi Kilgore

  3. Charting the Market

    1:49 a.m. Dec. 5, 2015

    - Barron's Online

  4. Oramed Could Double With Diabetes Blockbuster

    11:53 a.m. Nov. 23, 2015

    - Barron's Online

  5. Charting the Market

    10:25 p.m. March 27, 2015

    - Barron's Online

  6. Twitter, Tesla surge; BlackBerry slips

    5:21 p.m. Dec. 26, 2013

    - Wallace Witkowski

  7. Charting the Market

    5:22 a.m. Dec. 21, 2013

    - Barron's Online

  8. Charting the Market

    4:52 a.m. June 22, 2013

    - Barron's Online

  9. Oramed gets FDA approval for flagship drug plans

    10:04 a.m. May 17, 2013

    - MarketWatch.com

Analyst Ratings

/news/nonmarketwatch/company/us/ormp

Other News on ORMP

  1. 10-Q: ORAMED PHARMACEUTICALS INC.

    4:21 p.m. April 13, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  2. ORMP, MOGO, LIZI and LEAF among premarket gainers

    8:23 a.m. March 23, 2021

    - Seeking Alpha

  3. BCRX, NGA, SESN and KSU among premarket gainers

    8:23 a.m. March 22, 2021

    - Seeking Alpha

  4. Oramed reaches 25% enrollment in late-stage ORMD-0801 study

    8:43 a.m. March 16, 2021

    - Seeking Alpha

  5. NOK, SRGA among premarket losers

    9:17 a.m. Jan. 28, 2021

    - Seeking Alpha

  6. GME, OSTK, AQMS and PEI among premarket gainers

    9:22 a.m. Jan. 26, 2021

    - Seeking Alpha

  7. CRWD, ZS, WDR and OMER among premarket gainers

    9:27 a.m. Dec. 3, 2020

    - Seeking Alpha

  8. Oramed launches late-stage NASH study with oral insulin

    3:44 p.m. Dec. 2, 2020

    - Seeking Alpha

  9. MRNA, GME, GNW and QS among premarket gainers

    9:23 a.m. Nov. 30, 2020

    - Seeking Alpha

  10. RIOT, NVAX, MARA and SOL among midday movers

    12:23 p.m. Nov. 27, 2020

    - Seeking Alpha

  11. 10-K: ORAMED PHARMACEUTICALS INC.

    8:39 a.m. Nov. 24, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  12. Company News for Jul 16, 2020

    10:19 a.m. July 16, 2020

    - Zacks.com

  13. Oramed on go with late-stage studies on oral insulin

    10:22 a.m. July 15, 2020

    - Seeking Alpha

  14. Loading more headlines...
/news/pressrelease/company/us/ormp

Press Releases on ORMP

  1. Canada Jobs Due for Next Week

    4:00 p.m. April 1, 2021

    - Baystreet.ca

  2. Best Stocks To Buy Today? 4 Health Care Stocks To Know

    3:11 p.m. March 23, 2021

    - StockMarket.com

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.